HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery

Introduction Adolescent girls and young women (AGYW) in Africa have high HIV incidence despite scale‐up of HIV testing and HIV treatment. Placebo‐controlled trials of tenofovir‐based pre‐exposure prophylaxi (PrEP) in diverse populations demonstrated that PrEP works with close to 100% effectiveness i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the International AIDS Society Jg. 22; H. S4; S. e25298 - n/a
Hauptverfasser:	Celum, Connie L, Delany‐Moretlwe, Sinead, Baeten, Jared M, Straten, Ariane, Hosek, Sybil, Bukusi, Elizabeth A, McConnell, Margaret, Barnabas, Ruanne V, Bekker, Linda‐Gail
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland John Wiley & Sons, Inc 01.07.2019 John Wiley and Sons Inc
Schlagworte:	Acquired immune deficiency syndrome Adolescent Adolescents Africa AIDS Anti-HIV Agents - therapeutic use Antiretroviral drugs Birth control Costs Disease prevention Disease transmission Domestic violence Drug dosages Evaluation Family planning Female Health aspects Health attitudes HIV HIV infection HIV Infections - prevention & control HIV prevention Human immunodeficiency virus Humans Pre-Exposure Prophylaxis Prevention Prophylaxis Public health Qualitative research Reproductive health Risk taking Sexually transmitted diseases STD Studies Teenage girls Tenofovir - therapeutic use Women Young Adult young women Africa young women pre-exposure prophylaxis HIV prevention adolescents Africa
ISSN:	1758-2652, 1758-2652
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!